📅 2026 Update: Recent Developments in Drug Lawsuits

Since the original article was published, there have been significant developments in lawsuits related to drugs, including those involving Depakote. Notable changes include new lawsuits, settlements, and the growth of existing legal cases. The earlier article continues further down this page, providing foundational information on the topic.

🩺 📈 Growth of Depo-Provera Lawsuits

By June 2026, the number of lawsuits related to Depo-Provera had surged to over 5,500 cases. These lawsuits allege a connection between the contraceptive and brain tumors. This increase underscores the ongoing concerns regarding the safety of the drug and the potential for serious side effects.

⚖️ ⚡ Current Status of Ozempic Lawsuits

In June 2026, 3,763 lawsuits were consolidated in federal court in Pennsylvania. Plaintiffs allege that Ozempic and related GLP-1 receptor agonist drugs cause severe gastrointestinal injuries and vision loss. This consolidation aims to streamline the legal process for these claims.

💰 💼 Gardasil Settlement

In June 2026, Merck agreed to pay over $50 million to settle more than 200 Gardasil-related cases. This settlement includes cases previously dismissed in North Carolina and a long-running case in Los Angeles. This marks a significant financial commitment from the manufacturer to resolve ongoing litigation.

🏛️ 👩‍⚖️ Antitrust Lawsuit Against Eli Lilly and Novo Nordisk

On January 14, 2026, Strive Specialties Inc. filed an antitrust complaint against Eli Lilly and Novo Nordisk. The complaint accuses these companies of coordinating to suppress competition in the GLP-1 weight-loss drug market. This lawsuit highlights ongoing issues regarding competition and patient access to medications.

📌 Key Points Summary

  • The Depo-Provera MDL has grown to over 5,500 cases alleging brain tumors.
  • Ozempic lawsuits have reached 3,763 claims consolidated in Pennsylvania.
  • Merck settled for over $50 million regarding Gardasil-related cases.
  • An antitrust lawsuit was filed against Eli Lilly and Novo Nordisk.
  • Ongoing legal actions reflect the complexities of drug safety and liability.

💡 Tips for Understanding Drug Liability Lawsuits

Review the details of your specific situation with an attorney.

📄 📝 Understand Eligibility Criteria

For lawsuits related to Ozempic, individuals must have developed severe gastrointestinal injuries or vision loss after using the drug. For Depo-Provera cases, eligibility involves a diagnosis of brain tumors post-use. Knowing the criteria can help determine if you qualify for a claim.

⏰ 📅 Be Aware of Filing Deadlines

The first Depo-Provera lawsuit was filed on October 1, 2024. It's crucial to be aware that subsequent filings must adhere to applicable statutes of limitations. Missing these deadlines could prevent you from making a claim.

📊 📈 Track the Status of Litigation

As of June 2026, no trials for the Ozempic MDL had taken place, while bellwether trials are expected to begin in late 2026 or early 2027. Staying informed about the progress of these cases can provide insights into potential outcomes.

📑 🔍 Seek Government Resources

The FDA provides information on drug safety and adverse events. This resource can assist individuals seeking information related to pharmaceutical injuries. Utilizing government resources can help you understand the landscape of drug liability.

🛠️ 🤝 Consider Nonprofit Assistance

Nonprofit organizations may offer free legal assistance for individuals pursuing product liability claims. These organizations can be a valuable resource for those needing guidance in the legal process.

🏆 Free Options Ranked by User Reviews (2026)

No national paid service in this area met the review threshold, so this section lists free government and nonprofit resources available for those impacted by drug-related issues.

🥇 1. FDA

The FDA offers comprehensive information about drug safety and adverse effects. They help individuals understand potential risks associated with medications. Patients can report adverse events, contributing to ongoing safety assessments.

🥈 2. Legal Aid Organizations

Various nonprofit organizations provide free legal assistance to those pursuing product liability claims. These organizations typically focus on low-income individuals or those unable to afford legal services. They can help navigate the complexities of drug litigation.

🥉 3. State Health Departments

Many state health departments provide resources related to medication safety. They often have information on reporting adverse reactions and can guide individuals on how to proceed if they believe they have been harmed by a drug.

4️⃣ Community Health Clinics

Community health clinics often offer services that include legal guidance or referrals. They are especially beneficial for individuals from underserved populations. These clinics can connect patients with resources to help them understand their rights.

🔎 What to Check Before Paying for Help

  • 🔍 Look for free resources first.
  • 📜 Verify the credibility of any organization.
  • 💬 Read reviews from other users.
  • 📅 Understand the timeline for assistance.
  • 📞 Ask about any potential fees upfront.

❓ Frequently Asked Questions

❓ What are the potential side effects of Ozempic?

Ozempic may cause severe gastrointestinal injuries and vision loss, which are central to the ongoing lawsuits against it. It's important for users to monitor their health and report any adverse effects.

⚠️ Who can file a lawsuit related to Depo-Provera?

Individuals diagnosed with brain tumors after using Depo-Provera may be eligible to file a lawsuit. This growing litigation highlights serious health concerns tied to the contraceptive.

🔍 How are lawsuits consolidated in federal court?

Lawsuits are consolidated in federal court to streamline the legal process. This allows multiple claims to be heard together, which can be more efficient for the court system and plaintiffs.

📊 What is the current status of the Gardasil settlement?

As of June 2026, Merck has settled over 200 Gardasil-related cases for over $50 million. This resolution marks a significant step in addressing the claims against the vaccine.

📅 When might trials for Ozempic begin?

As of June 2026, no trials for the Ozempic MDL had started, but bellwether trials are expected to commence in late 2026 or early 2027. These initial trials will help set precedents for other cases.

📈 How can individuals stay informed about their cases?

Individuals should track the progress of lawsuits through reliable legal news sources and updates from their legal representatives. Staying informed is key to understanding the evolving landscape of drug litigation.

⚖️ Recent Cases Related to Drug Liability

Recent court rulings highlight ongoing issues regarding drug safety and liability. These cases reflect the complexities of product liability law, especially concerning pharmaceuticals like Depakote.

Explore more recent rulings in the news section for updates on ongoing litigation. more rulings on the news page.

End of October 2026 Update






A Brief Guide to Filing a Depakote Lawsuit:



What is Depakote?



Depakote is the brand name for Valproic acid. When used alone or with other medications, the drug is effective in treating certain types of seizures. Depakote, in addition to this application, may also be used to prevent migraines and treat manic episodes in people with bipolar disorder. Depakote belongs to a class of medications known as anticonvulsants; it is effective by increasing the amount of certain substances in the brain.



Depakote Side Effects:

Depakote Lawsuit


Depakote may cause side effects; please inform your doctor if any of the following Depakote side effects are severe or persistent:



• Common Depakote Side Effects Include: drowsiness; headache; diarrhea; constipation; dizziness; changes in appetite; agitation; uncontrollable shaking of the body; hair loss; sore throat; stuffed or runny nose; uncontrollable movements of the eyes; loss of coordination; abnormal thinking and memory loss.



Some Depakote side effects are classified as serious. If you experience the following Depakote side effects or those listed within the WARNING section of the drug’s packaging, please contact your doctor immediately:



• Severe Depakote Side Effects Include: unusual bleeding or bruising; fever; blisters or rash; itching; rash; difficulty breathing or swallowing; swollen glands; weakness in the joints; depression; suicidal thoughts and confusion

Depakote side effects may take other forms; if you experience any adverse reactions, please contact your doctor to discuss discontinuation.



Depakote FDA Information:



If properly monitored by a physician, patients can continue taking the drug without experiencing serious Depakote side effects. That being said, recent reports have found a link between taking a Depakote dosage and birth defects. The FDA, in response to said findings, has updated its warnings concerning Depakote side effects. The recently found effects, not surprisingly, have led to the imitation of multiple suits been filed by female users who took the drug prior to the release of pregnancy warnings.



Famous Depakote Lawsuits:



The most significant Depakote lawsuit was recently resolved when the Justice Department announced that manufacturer Abbott Laboratories is responsible for paying $1.6 billion as compensation for improperly marketing the medication. This Depakote lawsuit; however, was not related to Depakote side effects, but instead its illegal marketing practices. While it is not illegal to prescribe a Depakote dosage for a purpose not approved by the FDA, the company violated the law by actively marketing the drug for schizophrenia, autism and other off-label uses.



Although the most famous Depakote lawsuit dealt with fraudulent marketing practices, other Depakote lawsuits are filed because of side effects, including an active class-action Depakote lawsuit regarding birth defects. These Depakote lawsuits are filed by users who develop severe Depakote side effects as a result of proper use—a Depakote lawsuit cannot be filed if the user abused the drug. Those filing Depakote lawsuits seek compensation to offset the costs associated with their adverse reaction—Depakote lawsuits, if successfully filed, will award funds for medical expenses, lost wages and pain and suffering.



A number of Depakote lawsuits have been filed due to the drug’s link with birth defects. As a result of this data, the FDA required a warning concerning the risks of birth defects to be added to prescription information.



A more extensive study of Depakote side effects was released in 2010. This study of 98,000 female Depakote users concluded that, among other risks, a fetus being born with spina bifida was 12 times more likely to occur. Five other potential birth defects were observed to increase significantly as part of these Depakote side effects, including various heart conditions and cleft palate. As of the middle of 2012, a class action Depakote lawsuit regarding birth defects represented 27 women. These Depakote lawsuits are currently still pending.  



In 2009, the FDA concluded that Depakote increased the risk of suicidal urges and depression. This conclusion was reached after a review of several antiepileptic medications. Before this finding, the bulk of Depakote lawsuits, if filed adequately, would most likely have resulted in a settlement.



The outcome of the class action Depakote lawsuit over birth defects will determine whether litigation filed by other women is likely to be successful. Due to the strong links suggested by multiple studies between a Depakote dosage and birth defects, this case stands a strong chance of success. To avoid taking action after the statute of limitations in your state expires, consult with an attorney immediately to file a Depakote lawsuit.



Sources:



1. “Valproic Acid” United States National Library of Medicine retrieved from:



https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000677/



2. https://fdanews.com/newsletter/article?issueId=11836&articleId=109236



3. https://www.nytimes.com/2012/05/08/business/abbott-to-pay-1-6-billion-over-illegal-marketing.html



4. https://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm153869.htm